Brief: Annexin Pharmaceuticals Q4 Net Loss At SEK 10.5 Mln
Feb 5 (Reuters) - Annexin Pharmaceuticals AB (publ) ANNX.ST: Q4 PERIOD RESULT OF SEK -10.51 MILLION PLANS COST SAVINGS AND ACTIVITY POSTPONEMENT Source text: ID:nMFN9qBCjs Further company coverage: ANNX.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Annexin Pharmaceuticals AB (publ)
See all newsBrief: Annexin Pharmaceuticals Q3 Net Loss At SEK 9.5 Mln
Brief: Annexin Pharmaceuticals Q2 2026 Net Loss SEK 11.6 Mln
Brief: Annexin Pharmaceuticals Gets International Nonproprietary Name Drug Candidate Anxv
Brief: Annexin Pharmaceuticals Updates On Nine Patients Treated In Nexus Study
Brief: Annexin's Rights Issue 98% Subscribed